1. Pink Sheet

340B Fight: Lilly ‘Disagrees’ With HHS Advisory Stating Discounts To Contract Pharmacies Are Required

 
• By Cathy Kelly

Lilly will not change its 340B discount restrictions in light of the advisory, which was released after HHS was sued by hospitals and other groups seeking a regulatory response against pharma actions.

Claims That Contract Pharmacies Aren't Passing Along Discounts To Patients

Eli Lilly and Company is maintaining that its actions to withhold 340B drug discounts from contract pharmacies for most of its products are legal, even though the US Health and Human Services Department said in a recent advisory opinion that manufacturers are required by law to offer discounted prices to contract pharmacies.

“We’ve reviewed HHS’s statement and we disagree with their conclusion,” the company told the Pink Sheet

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access